Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Glucose Responsive Insulin
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Sponsor : Eli Lilly
Deal Size : $1,000.0 million
Deal Type : Acquisition
Lilly Announces Acquisition of Protomer Technologies
Details : Protomer's proprietary peptide- and protein-engineering platform is used to identify and synthesize molecules that can sense glucose or other endogenous modulators of protein activity.
Brand Name : Undisclosed
Molecule Type : Peptide
Upfront Cash : Undisclosed
July 14, 2021
Lead Product(s) : Glucose Responsive Insulin
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Sponsor : Eli Lilly
Deal Size : $1,000.0 million
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?